申萬宏源(06806.HK)“24申證D2”7月16日本息兌付並摘牌
格隆匯7月17日丨申萬宏源(06806.HK)公告,公司所屬子公司申萬宏源證券有限公司於2024年9月6日發行申萬宏源證券有限公司2024年面向專業投資者公開發行短期公司債券(第一期)(品種二)(以下簡稱“本期債券”),發行規模人民幣38億元,票面利率1.99%,期限313天,債券代碼148903,債券簡稱24申證D2。
本期債券兌付日爲2025年7月16日,摘牌日爲2025年7月16日,申萬宏源證券有限公司已按照《申萬宏源證券有限公司2024年面向專業投資者公開發行短期公司債券(第一期)募集說明書》相關約定,完成本期債券本息兌付並予以摘牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.